HCV patients have reduced levels of adiponectin and leptin, and increased levels of resistin, ghrelin and vizfatin, contributing to inflammation, insulin resistance, lipid disorders and atherosclerosis and consequently to the development of hypertension and obesity [8,21,22]. The gene discussed is ADIPOQ; the disease is obesity due to melanocortin 4 receptor deficiency.